University Of Witwatersrand, South Africa
Clinical trials sponsored by University Of Witwatersrand, South Africa, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could HIV treatment choice affect sleep? new study investigates Results expected Aug 2027 (estimated)
-
Could a shot for moms shield babies from deadly RSV?
Vaccine Recruiting nowThis large study tests an RSV vaccine given to pregnant women to see if it safely protects their babies from severe RSV infection in the first months of life. About 13,000 pregnant women in Africa will receive either the vaccine or a placebo. The study also closely monitors wheth…
Phase 3 • Sponsor: University of Witwatersrand, South Africa • Aim: Vaccine
Last updated Jun 27, 2026 12:35 UTC
-
Can a standard HIV pill rescue those who got infected on Long-Acting PrEP?
Disease control Recruiting nowThis study tests a daily combination pill (TLD) as first-line HIV treatment for 100 people who became infected with HIV despite receiving long-acting cabotegravir PrEP in the past year. Researchers will check if the pill can suppress the virus to undetectable levels after 6 month…
Phase 4 • Sponsor: University of Witwatersrand, South Africa • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC